Medication info
Daewon Acyclovir Tablets

Daewon Acyclovir Tablets

Prescription medicationTablet
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
Daewon Pharmaceutical Co., Ltd.
Appearance
Light blue circular tablets
Packaging
For domestic use: 30 tablets/bottle, 200 tablets/bottle; for export: 100 tablets (10 tablets/PTPX10)
Approval status
Active

MFDS item code 199301673 · Notified 1993.10.27 · Insurance code 671800550

Summary

Main use
Treatment and prevention of herpes simplex (including genital herpes), herpes zoster, and chickenpox in children
Who uses it
Adults · Children
Adult dosage
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer 200 mg of acyclovir per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended in severe primary infections. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or impaired gastrointestinal absorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) It is preferable to start administration as soon as possible after infection; in recurrent cases, administration should preferably begin at the first sign of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg of this medicine per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) Thereafter, the dose may be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be interrupted periodically every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg of this medicine per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or impaired gastrointestinal absorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this medicine per dose 5 times daily at approximately 4-hour intervals, except during sleeping hours, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunocompromise or impaired gastrointestinal absorption. 3) It is preferable to start administration as soon as possible after infection; the earlier treatment begins, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience adverse reactions affecting the central nervous system; therefore, use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the accumulated dose resulting from intravenous injection. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), this medicine should preferably be administered at 200 mg every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, this medicine should preferably be administered at a reduced dose of 800 mg per dose twice daily, at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, this medicine should preferably be administered at a reduced dose of 800 mg per dose 3 times daily, at approximately 8-hour intervals.
Children's dosage
○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients 1) Age 2 years and older: Follow the adult regimen. 2) Under 2 years of age: Administer 1/2 the adult dose. 3) There are currently no conclusive data on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children 2 years and older: Administer 20 mg of this medicine per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days.

Ingredients

Manufacturer
Daewon Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of herpes simplex (including genital herpes), herpes zoster, and chickenpox in children

  • Genital herpes
  • herpes simplex virus infection of the skin and mucosal tissues
  • herpes zoster viral infection
  • acute pain
  • chickenpox
View approved original text

This medication is used to treat and prevent infections caused by herpes simplex virus in the skin and mucosal tissues, including primary and recurrent genital herpes. It is also effective in treating herpes zoster viral infections and particularly helps alleviate acute pain. However, the complete efficacy for postherpetic neuralgia is yet to be confirmed. This medication is also applicable for treating chickenpox in children aged 2 years and older. Through this efficacy, it helps alleviate symptoms and treat conditions related to viral infections.

Dosage and Administration

Adult dosage

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer 200 mg of acyclovir per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended in severe primary infections. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or impaired gastrointestinal absorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) It is preferable to start administration as soon as possible after infection; in recurrent cases, administration should preferably begin at the first sign of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg of this medicine per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. 2) Thereafter, the dose may be reduced to 200 mg per dose 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be interrupted periodically every 6 ~ 12 months for evaluation. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg of this medicine per dose 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (e.g., after bone marrow transplantation) or impaired gastrointestinal absorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this medicine per dose 5 times daily at approximately 4-hour intervals, except during sleeping hours, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunocompromise or impaired gastrointestinal absorption. 3) It is preferable to start administration as soon as possible after infection; the earlier treatment begins, the better the effect. ○ Patients with renal impairment Patients with renal impairment are more likely to experience adverse reactions affecting the central nervous system; therefore, use caution, including by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the accumulated dose resulting from intravenous injection. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), this medicine should preferably be administered at 200 mg every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL per minute, this medicine should preferably be administered at a reduced dose of 800 mg per dose twice daily, at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL per minute, this medicine should preferably be administered at a reduced dose of 800 mg per dose 3 times daily, at approximately 8-hour intervals.

Children's dosage

○ Children 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients 1) Age 2 years and older: Follow the adult regimen. 2) Under 2 years of age: Administer 1/2 the adult dose. 3) There are currently no conclusive data on the prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children 2 years and older: Administer 20 mg of this medicine per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days.

Precautions

This medication should not be used in patients who are allergic to this drug or its components. Caution is advised for patients with poor kidney function as they may be more susceptible to psychological adverse reactions. Patients with compromised liver function should also use this medication cautiously as it might further worsen liver function. Use in young children, particularly infants and toddlers, should be minimized and only when necessary since there is insufficient safety data available. Elderly patients should exercise caution when using this medication as they are more likely to have decreased kidney function, which may result in prolonged drug retention and increased risk of side effects. Severe allergic reactions, such as anaphylactic shock, can occur rarely while using this drug; immediate discontinuation and medical assistance is needed if symptoms such as difficulty in breathing or low blood pressure appear. Skin rashes, itching, blisters, and fever may develop as hypersensitivity reactions; if these symptoms arise, discontinue usage and consult a physician. Neurological symptoms such as confusion, drowsiness, seizures, and hallucinations may occur, particularly in those with weak kidney function or in the elderly. Adequate hydration is necessary as the drug can burden the kidneys, making it crucial to avoid dehydration. This drug is most effective when used early in the course of the disease; if symptoms do not improve or worsen, consider alternative treatment. Women who are pregnant or may become pregnant should carefully weigh the benefits and risks of using this drug, and nursing mothers should discontinue breastfeeding while using it. Interactions may occur when used with other medications; patients taking other drugs should inform their physician or pharmacist. Serious side effects may result from overdose, thus the prescribed dosage must be strictly followed, and immediate medical attention should be sought in the event of overdose. Caution is advised during driving or operating dangerous machinery while on this medication due to the potential for impaired consciousness or drowsiness.

Side effects

  • Anaphylactic shock
  • anaphylactoid reaction
  • hypotension
  • dyspnea
  • chest tightness
  • photosensitivity reaction
  • fixed drug eruption
  • rash
  • fever
  • vesicles
Show 122 more
  • urticarial erythema
  • urticaria
  • alopecia
  • erythema multiforme
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • concentration difficulties
  • aggressive behavior
  • depersonalization
  • agitation
  • ataxia
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucinations
  • psychosis
  • convulsions
  • drowsiness
  • tremors
  • excitement
  • forgetfulness
  • insomnia
  • anxiety
  • soliloquy
  • paresthesia
  • ataxia
  • inability to walk
  • involuntary movements
  • nystagmus
  • dizziness
  • renal failure
  • crystalluria
  • elevated BUN
  • elevated serum creatinine
  • hematuria
  • proteinuria
  • urinary red blood cell casts
  • pyuria
  • leukotoxic vasculitis
  • lymphadenopathy
  • bleeding
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • hepatic impairment
  • jaundice
  • elevated AST
  • elevated ALT
  • elevated LDH
  • elevated ALP
  • elevated total bilirubin
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • loose stools
  • upper abdominal pain
  • gastric pain
  • abdominal pain
  • nausea
  • vomiting
  • dyspepsia
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • lethargy
  • malaise
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • hypertension
  • hypotension
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glycosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disorders
  • alopecia
  • sweating
  • hyponatremia
  • hypoproteinemia
  • elevated total cholesterol
  • elevated triglycerides
  • elevated serum potassium
  • decreased serum albumin
  • agitation
  • coma
  • convulsions
  • somnolence
  • confusion
  • hallucinations
  • excitement
  • seizure
  • stupor

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering, and it is recommended to keep it at room temperature between 1 and 30 degrees Celsius. Proper storage can help maintain the drug's effectiveness for a longer period.

Appearance and packaging

Appearance

Light blue circular tablets

Package unit

For domestic use: 30 tablets/bottle, 200 tablets/bottle; for export: 100 tablets (10 tablets/PTPX10)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.